Which BI-RADS® category indicates a benign finding that requires routine follow-up?

Which BI-RADS® category indicates a benign finding that requires routine follow-up?

• A. Category 1
• B. Category 2
• C. Category 3
• D. Category 4

Answer: (B)

The BI-RADS® system is a standardized classification for reporting mammography results, helping in both diagnosis and management of breast conditions. A BI-RADS® category of 2 specifically indicates a benign finding. This means that the abnormality seen in the imaging has a very high probability of being non-cancerous, such as a cyst or a fibroadenoma. The recommendation for a routine follow-up is essential to confirm that the benign nature of the finding remains unchanged over time, without any immediate cause for concern that would require more invasive evaluation. In contrast, a Category 1 indicates that the mammogram is negative, requiring no further action, while Catgeory 3 suggests a finding that is probably benign but should be monitored more closely than in Category 2. Category 4 shows suspicious findings that warrant further investigation, as they have a higher likelihood of being cancerous. Hence, the designation of Category 2 as benign with a recommendation for routine follow-up aligns with guidelines for managing benign breast conditions.

The BI-RADS® system is a standardized classification for reporting mammography results, helping in both diagnosis and management of breast conditions. A BI-RADS® category of 2 specifically indicates a benign finding. This means that the abnormality seen in the imaging has a very high probability of being non-cancerous, such as a cyst or a fibroadenoma. The recommendation for a routine follow-up is essential to confirm that the benign nature of the finding remains unchanged over time, without any immediate cause for concern that would require more invasive evaluation.

In contrast, a Category 1 indicates that the mammogram is negative, requiring no further action, while Catgeory 3 suggests a finding that is probably benign but should be monitored more closely than in Category 2. Category 4 shows suspicious findings that warrant further investigation, as they have a higher likelihood of being cancerous. Hence, the designation of Category 2 as benign with a recommendation for routine follow-up aligns with guidelines for managing benign breast conditions.